Hysterectomy for Uterine Disease in 2010: from Past to Future
Liselotte Mettler1, Wael Sammur2 and Thoralf Schollmeyer1
1Department of Obstetrics and Gynaecology, University Hospitals Schleswig-Holstein, Campus Kiel, Germany. 2German Medical Centre, Dubai Healthcare City (DHCC), Dubai, United Arab Emirates.
Abstract
Hysterectomies were unknown in the field of obstetrics and gynaecology until the 19th century. In the 20th century they were perhaps too frequently performed whereas the 21st century has witnessed a steep decline in hysterectomy numbers. It is therefore an opportune time to review the indications for hysterectomies, hysterectomy techniques and the present and future status of this surgical procedure. There is a widespread consensus that hysterectomies are primarily to be performed in cancer cases and obstetrical chaos situations even though minimal invasive surgical technologies (MIS) have made the procedure more patient friendly than the classical abdominal opening. Today, minimally invasive hysterectomies are performed as frequently as vaginal hysterectomies and the vaginal approach is the first choice if the correct indications are given. It is no longer necessary to open the abdomen; this procedure has been replaced by laparoscopic surgery. Laparoscopic and robotic-assisted laparoscopic surgery can also be indicated for hysterectomies in selected patients with gynaecological cancers. For women of reproductive age, laparoscopic myomectomies and numerous other uterine- preserving techniques are applied in a first treatment step of meno-metrorrhagia, uterine adenomyosis and submucous myoma. These interventions are only followed by a hysterectomy if the pathology prevails.
Readers of this also read:
- Hysterectomy for Uterine Disease in 2010: from Past to Future
- A Study of Gonadal Arteries in 30 Adult Human Cadavers
- Combinatorial Gene Therapy to Inhibit HIV: Improving Therapeutic Efficacy by Targeting Multiple Stages of the HIV-1 Replication Cycle Simultaneously
- The Role of Aldosterone Blockade in Patients with Hypertensive Heart and Cardiovascular Disease
- The Use of Soluble Transferrin Receptor in the Detection of rHuEPO Abuse in Sports